Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Effectiveness and safety of artesunate–amodiaquine versus artemether–lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6–120 months in Yaoundé, Cameroon: a randomized trial

Fig. 1

Trial profile of effectiveness and safety study on artesunate-amodiaquine (AS-AQ) and artemether-lumefantrine (AL) in Yaoundé, Cameroon. *Enrollment violation (1 participant had baseline parasitaemia > 200,000 parasites/µl, 2 had only positive results by malaria rapid diagnostic test and 2 had signs of severe malaria); Treatment violation (1 did not comply with the treatment procedure). **Enrollment violation (1 participant had baseline parasitaemia > 200,000 parasites/µl and 1 had only positive result by malaria rapid diagnostic test); Treatment violation (1 did not comply with the treatment procedure)

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us